These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35079981)

  • 1. Polarity protein Par3 sensitizes breast cancer to paclitaxel by promoting cell cycle arrest.
    Zhao Y; Peng H; Liang L; Li Y; Hu X; Wang B; Xu Y; Chen S
    Breast Cancer Res Treat; 2022 Feb; 192(1):75-87. PubMed ID: 35079981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel.
    Zhao W; Song Y; Xu B; Zhan Q
    Cancer Biol Ther; 2012 Feb; 13(3):156-63. PubMed ID: 22353935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability.
    Luo Y; Li D; Ran J; Yan B; Chen J; Dong X; Liu Z; Liu R; Zhou J; Liu M
    Protein Cell; 2014 Jun; 5(6):469-79. PubMed ID: 24748116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH; Jiang JD; Holland JF; Perez-Soler R
    Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis.
    Moktan S; Ryppa C; Kratz F; Raucher D
    Invest New Drugs; 2012 Feb; 30(1):236-48. PubMed ID: 20938714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells.
    Amaya C; Luo S; Baigorri J; Baucells R; Smith ER; Xu XX
    BMC Cancer; 2021 Sep; 21(1):981. PubMed ID: 34470602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosolic Cl- Affects the Anticancer Activity of Paclitaxel in the Gastric Cancer Cell Line, MKN28 Cell.
    Tanaka S; Miyazaki H; Shiozaki A; Ichikawa D; Otsuji E; Marunaka Y
    Cell Physiol Biochem; 2017; 42(1):68-80. PubMed ID: 28554181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
    Rathinasamy K; Jindal B; Asthana J; Singh P; Balaji PV; Panda D
    BMC Cancer; 2010 May; 10():213. PubMed ID: 20482847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.
    Duangmano S; Sae-Lim P; Suksamrarn A; Domann FE; Patmasiriwat P
    BMC Complement Altern Med; 2012 Oct; 12():185. PubMed ID: 23062075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity.
    Sun X; Li D; Yang Y; Ren Y; Li J; Wang Z; Dong B; Liu M; Zhou J
    J Pathol; 2012 Mar; 226(4):666-73. PubMed ID: 21989536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of polarity protein Par3 is mediated by transcription factor Sp1 in breast cancer.
    Zhao Y; Yao D; Li Y; Zhang S; Tao Z; Zhang L; Hu X; Wang B; Chen S
    Biochem Biophys Res Commun; 2021 Jul; 561():172-179. PubMed ID: 34023783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
    Luo Y; Wang X; Wang H; Xu Y; Wen Q; Fan S; Zhao R; Jiang S; Yang J; Liu Y; Li X; Xiong W; Ma J; Peng S; Zeng Z; Li X; Phillips JB; Li G; Tan M; Zhou M
    PLoS One; 2015; 10(9):e0138955. PubMed ID: 26406239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
    Dinić J; Ríos-Luci C; Karpaviciene I; Cikotiene I; Fernandes MX; Pešić M; Padrón JM
    Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.
    Bonham MJ; Galkin A; Montgomery B; Stahl WL; Agus D; Nelson PS
    J Natl Cancer Inst; 2002 Nov; 94(21):1641-7. PubMed ID: 12419791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
    Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
    Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromodomain‑containing protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2‑antagonist/killer protein.
    Ma J; Niu W; Wang X; Zhou Y; Wang H; Liu F; Liu Y; Guo J; Xiong W; Zeng Z; Fan S; Li X; Nie X; Li G; Gui R; Luo Y; Zhou M
    Oncol Rep; 2019 Mar; 41(3):1487-1496. PubMed ID: 30592293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enriched variations in TEKT4 and breast cancer resistance to paclitaxel.
    Jiang YZ; Yu KD; Peng WT; Di GH; Wu J; Liu GY; Shao ZM
    Nat Commun; 2014 May; 5():3802. PubMed ID: 24823476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells.
    Banerjee M; Singh P; Panda D
    FEBS J; 2010 Aug; 277(16):3437-48. PubMed ID: 20646066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
    Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
    Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.